Apyx Medical Corp (APYX)
About Apyx Medical Corp
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $52.8M
- Net income
- -$11.2M
- Total assets
- $66.8M
- Market cap
- $187.2M
- Gross margin
- 62.5%
- Operating margin
- -12.2%
- Net margin
- -21.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $52.8M
- Cost of revenue
- $19.8M
- Gross profit
- $33.0M
- Operating expenses
- $39.5M
- Operating income
- -$6.4M
- Income tax
- $270.0K
- Net income
- -$11.1M
- EPS (basic)
- $-0.27
Balance sheet
- Total assets
- $66.8M
- Current assets
- $58.5M
- Total liabilities
- $52.0M
- Current liabilities
- $11.7M
- Shareholders’ equity
- $14.8M
Cash flow
- Operating cash flow
- -$8.0M
- Investing cash flow
- -$1.1M
- Financing cash flow
- $9.6M
- Net cash flow
- $465.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $187.2M
- Shares outstanding
- 47.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 6, 1994
Apyx Medical Corp (APYX) Stock Price
- Reported a net loss of $11.2M in FY2025.
- Revenue grew 91% from FY2020 to FY2025.
- Gross margin of 62.5%, net margin -21.0%.
- Trading 19% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Apyx Medical Corp.
Write a review
News about Apyx Medical Corp
News & sentiment via Polygon.io
Apyx Medical Corp: frequently asked questions
Is Apyx Medical Corp an American company?
Apyx Medical Corp is a US-based company headquartered in Clearwater, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Apyx Medical Corp headquartered?
Apyx Medical Corp is headquartered in Clearwater, Florida, United States.
Is Apyx Medical Corp publicly traded?
Yes — Apyx Medical Corp is a publicly traded company. Its stock trades under the ticker symbol APYX on the NASDAQ.
What does Apyx Medical Corp do?
Apyx Medical Corp is an American Medical Devices company in the Health & Beauty sector.
